Anti-MS4A6A antibodies and methods of use thereof

US12215149B2 · kind B2 · utility

Assignee

• Alector LLC

Inventors

• Philip Kong · San Francisco, US
• Herve Rhinn · New York, US
• Tina SCHWABE · San Francisco, US
• Angie Yee · San Francisco, US
• Arnon Rosenthal · Woodside, US

Key dates

• Filing date: Apr 18, 2022
• Grant date: Feb 4, 2025
• Expiry date: Sep 7, 2042

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2317/92
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, antibodies, antibody fragments, etc., that specifically bind a MS4A6A polypeptide, e g., a mammalian MS4A6A or human MS4A6A, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.